keyword
https://read.qxmd.com/read/38702645/long-term-survival-after-hepatic-resection-for-colorectal-liver-metastases-a-single-center-study-in-iran
#1
JOURNAL ARTICLE
Seyed Morteza Pourfaraji, Mehdi Nazari Moghadam, Ali Mohammad Moradi, Fatemeh Ojaghi Shirmard, Narjes Mohammadzadeh, Ali Jafarian
BACKGROUND: Surgical resection of colorectal cancer liver metastasis (CRLM) has been associated with improved survival in these patients. The purpose of this study was to investigate the usefulness of liver metastasectomy, also finding independent factors related to survival after liver metastasectomy. METHODS: In a retrospective study, all patients with CRLM who underwent resection of liver metastases between 2012 and 2022 at Imam Khomeini Hospital Complex in Tehran, Iran, were enrolled...
May 3, 2024: BMC Surgery
https://read.qxmd.com/read/38702350/feasibility-safety-efficacy-and-potential-scaling-up-of-sofosbuvir-based-hcv-treatment-in-central-and-west-africa-tac-anrs-12311-trial
#2
MULTICENTER STUDY
Karine Lacombe, Raoul Moh, Corine Chazallon, Maud Lemoine, Babacar Sylla, Fatoumata Fadiga, Jerôme Le Carrou, Fabienne Marcellin, Charles Kouanfack, Laura Ciaffi, Michelle Tagni Sartre, Magloire Biwole Sida, Alpha Diallo, Joel Gozlan, Moussa Seydi, Viviane Cissé, Christine Danel, Pierre Marie Girard, Thomas d'Aquin Toni, Albert Minga, Sylvie Boyer, Patrizia Carrieri, Alain Attia
Access to Hepatis C treatment in Sub-Saharan Africa is a clinical, public health and ethical concern. The multi-country open-label trial TAC ANRS 12311 allowed assessing the feasibility, safety, efficacy of a specific care model of HCV treatment and retreatment in patients with hepatitis C in Sub Saharan Africa. Between November 2015 and March 2017, with follow-up until mid 2019, treatment-naïve patients with HCV without decompensated cirrhosis or liver cancer were recruited to receive 12 week-treatment with either sofosbuvir + ribavirin (HCV genotype 2) or sofosbuvir + ledipasvir (genotype 1 or 4) and retreatment with sofosbuvir + velpatasvir + voxilaprevir in case of virological failure...
May 3, 2024: Scientific Reports
https://read.qxmd.com/read/38702214/deep-learning-radiomics-model-of-contrast-enhanced-ct-for-differentiating-the-primary-source-of-liver-metastases
#3
JOURNAL ARTICLE
Wenjing Jia, Fuyan Li, Yi Cui, Yong Wang, Zhengjun Dai, Qingqing Yan, Xinhui Liu, Yuting Li, Huan Chang, Qingshi Zeng
RATIONALE AND OBJECTIVES: To develop and validate a deep learning radiomics (DLR) model based on contrast-enhanced computed tomography (CT) to identify the primary source of liver metastases. MATERIALS AND METHODS: In total, 657 liver metastatic lesions, including breast cancer (BC), lung cancer (LC), colorectal cancer (CRC), gastric cancer (GC), and pancreatic cancer (PC), from 428 patients were collected at three clinical centers from January 2018 to October 2023 series...
May 2, 2024: Academic Radiology
https://read.qxmd.com/read/38701937/cancer-stem-like-cells-in-uveal-melanoma-novel-insights-and-therapeutic-implications
#4
REVIEW
Alessandra Loda, Francesco Semeraro, Silvia Parolini, Roberto Ronca, Sara Rezzola
Uveal melanoma (UM) is the most common primary ocular tumor in the adult population. Even though these primary tumors are successfully treated in 90% of cases, almost 50% of patients ultimately develop metastasis, mainly in the liver, via hematological dissemination, with a median survival spanning from 6 to 12 months after diagnosis. In this context, chemotherapy regimens and molecular targeted therapies have demonstrated poor response rates and failed to improve survival. Among the multiple reasons for therapy failure, the presence of cancer stem-like cells (CSCs) represents the main cause of resistance to anticancer therapies...
May 1, 2024: Biochimica et Biophysica Acta. Reviews on Cancer
https://read.qxmd.com/read/38701867/ddx39b-protects-against-sorafenib-induced-ferroptosis-by-facilitating-the-splicing-and-cytoplasmic-export-of-gpx4-pre-mrna-in-hepatocellular-carcinoma
#5
JOURNAL ARTICLE
Qin Li, Hang Yuan, Gang Zhao, Deqiong Ou, Jie Zhang, Liang Li, Siqi Li, Tianyu Feng, Rui Gu, Qiming Kou, Qijing Wang, Shan Li, Guanru Wang, Minghui Zhao, Huayang Yu, Jie Qu, Ping Lin, Kai Li
Hepatocellular carcinoma (HCC) is the main histological subtype of primary liver cancer and remains one of the most common solid malignancies globally. Ferroptosis was recently defined as an iron-catalyzed form of regulated necrosis. Because cancer cells exhibit higher iron requirements than noncancer cells, treatment with ferroptosis-inducing compounds may be a feasible strategy for cancer therapy. However, cancer cells develop acquired resistance to evade ferroptosis, and the mechanisms responsible for ferroptosis resistance are not fully clarified...
May 1, 2024: Biochemical Pharmacology
https://read.qxmd.com/read/38701690/patterns-timing-and-predictors-of-recurrence-following-pancreaticoduodenectomy-for-distal-cholangiocarcinoma-an-international-multicentre-retrospective-cohort-study
#6
JOURNAL ARTICLE
Peter Lz Labib, Thomas B Russell, Jemimah L Denson, Mark A Puckett, Fabio Ausania, Elizabeth Pando, Keith J Roberts, Ambareen Kausar, Vasileios K Mavroeidis, Ricky H Bhogal, Gabriele Marangoni, Sarah C Thomasset, Adam E Frampton, Duncan R Spalding, Pavlos Lykoudis, Ruben Bellotti, Nassir Alhaboob, Parthi Srinivasan, Hassaan Bari, Andrew Smith, Ismael Dominguez-Rosado, Daniel Croagh, Rohan G Thakkar, Dhanny Gomez, Michael A Silva, Pierfrancesco Lapolla, Andrea Mingoli, Brian R Davidson, Alberto Porcu, Nehal S Shah, Zaed Z Hamady, Bilal A Al-Sarireh, Alejandro Serrablo, Somaiah Aroori
INTRODUCTION: Patients undergoing pancreaticoduodenectomy for distal cholangiocarcinoma (dCCA) often develop cancer recurrence. Establishing timing, patterns and risk factors for recurrence may help inform surveillance protocol strategies or select patients who could benefit from additional systemic or locoregional therapies. This multicentre retrospective cohort study aimed to determine timing, patterns, and predictive factors of recurrence following pancreaticoduodenectomy for dCCA...
April 22, 2024: European Journal of Surgical Oncology
https://read.qxmd.com/read/38700800/comparison-of-hospital-volume-and-risk-standardized-mortality-rate-as-a-proxy-for-hospital-quality-in-complex-oncologic-hepatopancreatobiliary-surgery
#7
JOURNAL ARTICLE
William T Julian, Mohamedraed Elshami, John B Ammori, Jeffrey M Hardacre, Lee M Ocuin
BACKGROUND: Centralization of hepatopancreatobiliary procedures to more experienced centers has been recommended but remains controversial. Hospital volume and risk-stratified mortality rates (RSMR) are metrics for interhospital comparison. We compared facility operative volume with facility RSMR as a proxy for hospital quality. PATIENTS AND METHODS: Patients who underwent surgery for liver (LC), biliary tract (BTC), and pancreatic (PDAC) cancer were identified in the National Cancer Database (2004-2018)...
May 3, 2024: Annals of Surgical Oncology
https://read.qxmd.com/read/38700632/an-electronic-health-record-model-for-predicting-risk-of-hepatic-fibrosis-in-primary-care-patients
#8
JOURNAL ARTICLE
Aaron P Thrift, Theresa H Nguyen Wenker, Kyler Godwin, Maya Balakrishnan, Hao T Duong, Rohit Loomba, Fasiha Kanwal, Hashem B El-Serag
BACKGROUND: One challenge for primary care providers caring for patients with nonalcoholic fatty liver disease is to identify those at the highest risk for clinically significant liver disease. AIM: To derive a risk stratification tool using variables from structured electronic health record (EHR) data for use in populations which are disproportionately affected with obesity and diabetes. METHODS: We used data from 344 participants who underwent Fibroscan examination to measure liver fat and liver stiffness measurement [LSM]...
May 3, 2024: Digestive Diseases and Sciences
https://read.qxmd.com/read/38700058/peritoneal-dialysis-in-an-end-stage-renal-disease-patient-with-massive-ascites-and-primary-liver-cancer
#9
JOURNAL ARTICLE
Lulu Sun, Chunmei Liang, Yuqin Wang, Hui Li, Lijun Yao, Huajun Jiang
End-stage renal disease (ESRD) coexisted with cirrhosis, ascites, and primary liver cancer represents an extraordinarily rare clinical condition that typically occurs in very late-stage decompensated cirrhosis and is associated with an extremely poor prognosis. We present a case of a 68-year-old male patient with ESRD who experienced various decompensated complications of liver cirrhosis, particularly massive ascites and hepatic space-occupying lesions. Peritoneal dialysis (PD) catheter insertion and continuous ambulatory peritoneal dialysis (CAPD) treatment were successfully performed...
December 2024: Renal Failure
https://read.qxmd.com/read/38699639/nanocage-incorporated-engineered-destabilized-3-utr-are-of-erbb2-inhibits-tumor-growth-and-liver-and-lung-metastasis-in-egfr-t790m-osimertinib-and-trastuzumab-resistant-and-erbb2-expressing-nsclc-via-the-reduction-of-erbb2
#10
JOURNAL ARTICLE
Chidiebere U Awah, Joo Sun Mun, Aloka Paragodaarachchi, Baris Boylu, Martin Nzegwu, Hiroshi Matsui, Olorunseun Ogunwobi
Non-small cell lung cancer (NSCLC) caused more deaths in 2017 than breast cancer, prostate, and brain cancers combined. This is primarily due to their aggressive metastatic nature, leading to more fatal rates of cancer patients. Despite this condition, there are no clinically approved drugs that can target metastasis. The NSCLC with EGFR T790M-overexpressing HER2 shows the resistance to osimertinib and trastuzumab starting 10-18 months after the therapy, and thus prospects are grim to these patients. To target the recalcitrant ERBB2 driver oncogene, we developed two engineered destabilizing 3'UTR ERBB2 constructs that degrade the endogenous ERBB2 transcript and proteins by overwriting the encoded endogenous ERBB2 mRNA with the destabilizing message...
2024: Frontiers in Oncology
https://read.qxmd.com/read/38698687/construction-and-validation-of-wch-nomogram-for-predicting-the-prognosis-after-resection-of-colorectal-liver-metastases
#11
JOURNAL ARTICLE
Chuang Jiang, Weixing Liu, Zechuan Jin, Ling Lan, Lin Xu, Ao Du, Song Peng, Yong Zeng, Haichuan Wang, Mingheng Liao, Jin Zhou
BACKGROUND: The prognostic predictive tool for patients with colorectal liver metastasis (CRLM) is limited and the criteria for administering preoperative neoadjuvant chemotherapy in CRLM patients remain controversial. METHODS: This study enrolled 532 CRLM patients at West China Hospital (WCH) from January 2009 to December 2019. Prognostic factors were identified from the training cohort to construct a WCH-nomogram and evaluating accuracy in the validation cohort...
May 2024: Cancer Medicine
https://read.qxmd.com/read/38698462/ficolin-3-promotes-ferroptosis-in-hcc-by-downregulating-ir-srebp-axis-mediated-mufa-synthesis
#12
JOURNAL ARTICLE
Yanmei Yuan, Junting Xu, Quanxin Jiang, Chuanxin Yang, Ning Wang, Xiaolong Liu, Hai-Long Piao, Sijia Lu, Xianjing Zhang, Liu Han, Zhiyan Liu, Jiabin Cai, Fang Liu, Suzhen Chen, Junli Liu
BACKGROUND: Targeting ferroptosis has been identified as a promising approach for the development of cancer therapies. Monounsaturated fatty acid (MUFA) is a type of lipid that plays a crucial role in inhibiting ferroptosis. Ficolin 3 (FCN3) is a component of the complement system, serving as a recognition molecule against pathogens in the lectin pathway. Recent studies have reported that FCN3 demonstrates inhibitory effects on the progression of certain tumors. However, whether FCN3 can modulate lipid metabolism and ferroptosis remains largely unknown...
May 3, 2024: Journal of Experimental & Clinical Cancer Research: CR
https://read.qxmd.com/read/38696452/upregulation-of-lhpp-by-sarna-inhibited-hepatocellular-cancer-cell-proliferation-and-xenograft-tumor-growth
#13
JOURNAL ARTICLE
Chuan-Qian Bi, Tao Kang, Yu-Kang Qian, Moorim Kang, Xu-Hui Zeng, Long-Cheng Li
Hepatocellular carcinoma (HCC) is the most common primary liver cancer worldwide and no pharmacological treatment is available that can achieve complete remission of HCC. Phospholysine phosphohistidine inorganic pyrophosphate phosphatase (LHPP) is a recently identified HCC tumor suppressor gene which plays an important role in the development of HCC and its inactivation and reactivation has been shown to result in respectively HCC tumorigenesis and suppression. Small activating RNAs (saRNAs) have been used to achieve targeted activation of therapeutic genes for the restoration of their encoded protein through the RNAa mechanism...
2024: PloS One
https://read.qxmd.com/read/38696372/surveillance-mri-is-associated-with-improved-survival-in-patients-with-primary-sclerosing-cholangitis
#14
MULTICENTER STUDY
Natassia Tan, Natalie Ngu, Thomas Worland, Tanya Lee, Tobie Abrahams, Elliot Freeman, Nicholas Hannah, Kathryn Gazelakis, Richie G Madden, Kate D Lynch, Zina Valaydon, Siddharth Sood, Anouk Dev, Sally Bell, Alexander J Thompson, John Nik Ding, Amanda J Nicoll, Ken Liu, Keval Pandya, Paul Gow, John Lubel, William Kemp, Stuart K Roberts, Ammar Majeed
BACKGROUND: The benefits of regular surveillance imaging for cholangiocarcinoma in patients with primary sclerosing cholangitis (PSC) are unclear. Hence, we aimed to evaluate the impact of regular magnetic resonance cholangiopancreatography (MRCP) on outcomes of patients with PSC in Australia, where the practice of MRCP surveillance is variable. METHODS: The relationship between MRCP surveillance and survival outcomes was assessed in a multicenter, retrospective cohort of patients with PSC from 9 tertiary liver centers in Australia...
May 1, 2024: Hepatology Communications
https://read.qxmd.com/read/38694920/chinese-medicine-in-the-treatment-of-non-alcoholic-fatty-liver-disease-based-on-network-pharmacology-a-review
#15
REVIEW
Shihao Zheng, Chengyuan Xue, Size Li, Xiaobin Zao, Xiaoke Li, Qiyao Liu, Xu Cao, Wei Wang, Wenying Qi, Peng Zhang, Yongan Ye
Non-alcoholic fatty liver disease (NAFLD) is a clinicopathological syndrome characterized by abnormalities in hepatic fat deposition, the incidence of which has been increasing year by year in recent years. It has become the largest chronic liver disease globally and one of the important causes of cirrhosis and even primary liver cancer formation. The pathogenesis of NAFLD has not yet been fully clarified. Modern medicine lacks targeted clinical treatment protocols for NAFLD, and most drugs lack efficacy and have high side effects...
2024: Frontiers in Pharmacology
https://read.qxmd.com/read/38694823/organ-on-a-chip-for-studying-immune-cell-adhesion-to-liver-sinusoidal-endothelial-cells-the-potential-for-testing-immunotherapies-and-cell-therapy-trafficking
#16
JOURNAL ARTICLE
James I Kennedy, Scott P Davies, Peter W Hewett, Alex L Wilkinson, Ye H Oo, Wei-Yu Lu, Alicia J El Haj, Shishir Shetty
Immunotherapy has changed the landscape of treatment options for patients with hepatocellular cancer. Checkpoint inhibitors are now standard of care for patients with advanced tumours, yet the majority remain resistant to this therapy and urgent approaches are needed to boost the efficacy of these agents. Targeting the liver endothelial cells, as the orchestrators of immune cell recruitment, within the tumour microenvironment of this highly vascular cancer could potentially boost immune cell infiltration. We demonstrate the successful culture of primary human liver endothelial cells in organ-on-a-chip technology followed by perfusion of peripheral blood mononuclear cells...
2024: Frontiers in Cell and Developmental Biology
https://read.qxmd.com/read/38693425/surgical-resection-of-double-advanced-pancreatic-neuroendocrine-tumors-with-multiple-renal-cell-carcinoma-associated-with-von-hippel-lindau-disease
#17
JOURNAL ARTICLE
Yoshiyuki Shibata, Takeshi Sudo, Sho Tazuma, Takashi Onoe, Atsushi Yamaguchi, Masanobu Shigeta, Kazuya Kuraoka, Rie Yamamoto, Shinya Takahashi, Hirotaka Tashiro
Von Hippel-Lindau (VHL) disease, an autosomal dominant genetic disorder caused by a germline mutation, is associated with non-functional and slow-growing pancreatic neuroendocrine tumor (PNET) and kidney cancer. We describe the case of a 46 year-old man with a 35 mm mass in the pancreatic head causing stricture of the bile duct and main pancreatic duct, a 55 mm mass in the pancreatic tail causing obstruction of the splenic vein (SV), and multiple masses of > 36 mm on both kidneys...
May 2, 2024: Clinical Journal of Gastroenterology
https://read.qxmd.com/read/38691255/bridging-current-knowledge-gap-better-primary-colorectal-cancer-prevention-in-people-living-with-metabolic-dysfunction-associated-steatotic-liver
#18
JOURNAL ARTICLE
Agostino Di Ciaula, Piero Portincasa
No abstract text is available yet for this article.
April 30, 2024: Internal and Emergency Medicine
https://read.qxmd.com/read/38691204/predicting-response-of-hepatoblastoma-primary-lesions-to-neoadjuvant-chemotherapy-through-contrast-enhanced-computed-tomography-radiomics
#19
JOURNAL ARTICLE
Yanlin Yang, Haoru Wang, Jiajun Si, Li Zhang, Hao Ding, Fang Wang, Ling He, Xin Chen
OBJECTIVE: To investigate the clinical value of contrast-enhanced computed tomography (CECT) radiomics for predicting the response of primary lesions to neoadjuvant chemotherapy in hepatoblastoma. METHODS: Clinical and CECT imaging data were retrospectively collected from 116 children with hepatoblastoma who received neoadjuvant chemotherapy. Tumor response was assessed according to the Response Evaluation Criteria in Solid Tumors (RECIST). Subsequently, they were randomly stratified into a training cohort and a test cohort in a 7:3 ratio...
April 30, 2024: Journal of Cancer Research and Clinical Oncology
https://read.qxmd.com/read/38690047/prognostic-value-of-a-nomogram-model-for-postoperative-liver-metastasis-of-colon-cancer
#20
JOURNAL ARTICLE
De-Xin Cheng, Kang-Di Xu, Han-Bo Liu, Yi Liu
BACKGROUND: Colon cancer is one of the most common malignant tumors of the digestive system. Liver metastasis after colon cancer surgery is the primary cause of death in patients with colon cancer. AIM: To construct a novel nomogram model including various factors to predict liver metastasis after colon cancer surgery. METHODS: We retrospectively analyzed 242 patients with colon cancer who were admitted and underwent radical resection for colon cancer in Zhejiang Provincial People's Hospital from December 2019 to December 2022...
April 27, 2024: World Journal of Gastrointestinal Surgery
keyword
keyword
23184
1
2
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.